Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 155M | 144M |
| Cost of revenue | 41M | 39M |
| Gross profit | 114M | 106M |
| Research and development | 12M | 17M |
| Selling, general and administrative | 55M | 53M |
| Operating expenses | 116M | 117M |
| Operating income | −3M | −12M |
| Net income | −20M | −14M |
| Earnings per share | −0.12 | −0.09 |
| Earnings per share, diluted | −0.12 | −0.09 |
| Weighted average shares | 167M | 152M |
| Weighted average shares, diluted | 167M | 152M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26M | 29M | 43M | 17M | 19M | 26M | 26M | 18M |
| Receivables | 84M | 90M | 81M | 80M | 79M | 79M | 67M | 74M |
| Inventory | 93M | 93M | 70M | 73M | 57M | 53M | 46M | 43M |
| Current assets | 229M | 238M | 229M | 211M | 213M | 209M | 195M | 191M |
| Property, plant and equipment | 12M | 12M | 13M | 14M | 15M | 15M | 15M | 16M |
| Total assets | 246M | 256M | 249M | 232M | 236M | 233M | 221M | 218M |
| Current liabilities | 91M | 96M | 90M | 259M | 89M | 91M | 86M | 80M |
| Total liabilities | 237M | 242M | 234M | 259M | 264M | 267M | 261M | 256M |
| Equity | 9M | 14M | 15M | −27M | −28M | −34M | −40M | −38M |
| Shares outstanding | — | 188M | — | — | — | 152M | — | — |
| Shares issued | — | 188M | — | — | — | 152M | — | — |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −28M | −23M |
| Depreciation and amortisation | 2M | 2M |
| Share-based compensation | 10M | 13M |
| Capital expenditure | 317,000 | 2M |
| Investing cash flow | 16M | 19M |
| Financing cash flow | 14M | 940,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator